Document is current
Any future updates will be listed below
-
Authors
,
Tonelli, Marcello https://orcid.org/0000-0002-0846-3187
Lloyd, Anita M.
Bello, Aminu K.
James, Matthew T.
Klarenbach, Scott W.
McAlister, Finlay A.
Manns, Braden J.
Tsuyuki, Ross T.
Hemmelgarn, Brenda R.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (Operating grant - IHS 120272)
- License Information
-
More Information
Article History
Received: 16 March 2018
Accepted: 6 March 2019
First Online: 25 March 2019
Ethics approval and consent to participate
: The institutional review boards at the Universities of Calgary and Alberta approved the study (REB14–0884, Pro00053469) with a waiver of consent granted.
: Not applicable.
: MT holds research funding from Merck, Canada (funds to institution). M.J. receives salary support from a CIHR New Investigator Award and holds an investigator-initiated research grant funded by Amgen, Canada. R.T. has the following disclosures: (Investigator-Initiated Research Grant: Merck; Speaking fees: Merck, Sandoz (Japan); President, SMHEART CONSULTING, INC.; Board of Directors, Hypertension Canada). The other authors have no conflicts of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
